Affiliation:
1. Department of Neurology and Pediatrics Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, The George Washington University, Washington, DC
Abstract
Plexiform neurofibromas are one of the most common and disabling features of neurofibromatosis 1. Treatment options for patients with plexiform neurofibromas have been limited, with surgery being the primary option for patients with progressive lesions causing significant morbidity. Trials have evaluated other treatment approaches, including the use of antihistamines, maturation agents, and antiangiogenic agents. The design of such trials and entry criteria have been quite variable, and results have been difficult to interpret. As more is understood concerning the molecular genetic underpinnings of plexiform neurofibromas, new avenues of treatment are being explored. Evaluation of clinical trials is challenging because of the unpredictable nature of plexiform neurofibromas and difficulties in measuring objective responses. The use of innovative neuroimaging techniques and other outcome measures may greatly improve the design of trials and evaluation of potential effective agents. (J Child Neurol 2002;17:638-641).
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference18 articles.
1. Plexiform neurofibromas
2. Woodruff JM, Lourea HP, Louis DN, Scheitauer BW: Neurofibroma, in Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours, Pathology and Genetics of Tumors of the Nervous System. Lyon, France, IAR,C Press , 2000, 167-168.
3. VON RECKLINGHAUSEN NEUROFIBROMATOSIS
4. The clinical and diagnostic implications mosaicism in the neurofibromatoses
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献